Sandoz Gets Claims Nixed In UTC's Generic Remodulin Fight
A New Jersey federal judge overseeing United Therapeutics Corp.'s patent litigation over Sandoz Inc.'s proposed generic version of hypertension drug Remodulin, on Monday tossed both parties' claims regarding one of the...To view the full article, register now.
Already a subscriber? Click here to view full article